As of July 2024, ResMed has a market cap of $30.80B. This makes ResMed the world's 586th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $27.12B | 9.91% |
2023 | $24.67B | -17.83% |
2022 | $30.03B | -13.47% |
2021 | $34.70B | 31.40% |
2020 | $26.41B | 24.34% |
2019 | $21.24B | 37.56% |
2018 | $15.44B | 44.86% |
2017 | $10.66B | 28.09% |
2016 | $8.32B | 15.32% |
2015 | $7.22B | 7.20% |
2014 | $6.73B | 30.94% |
2013 | $5.14B | 34.52% |
2012 | $3.82B | 59.51% |
2011 | $2.40B | -29.23% |
2010 | $3.38B | 17.71% |
2009 | $2.88B | 10.63% |
2008 | $2.60B | -9.92% |
2007 | $2.89B | -6.00% |
2006 | $3.07B | 20.57% |
2005 | $2.55B | 62.29% |
2004 | $1.57B | 14.31% |
2003 | $1.37B | 4.43% |
2002 | $1.31B | -48.13% |
2001 | $2.53B | 43.27% |
2000 | $1.77B | 111.42% |
1999 | $836.47M | - |